Mechanistic evaluation of PPARα-Mediated Hepatocarcinogenesis: Are we there yet?

Toxicological Sciences

Volumn 101, Issue 1, 2008, Pages 1-3

  Peters, Jeffrey M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Humanized mouse models; Liver cancer; Peroxisome proliferator activated receptor ; Peroxisome proliferators

Indexed keywords

ACYL COENZYME A OXIDASE; ANTILIPEMIC AGENT; COMPLEMENTARY DNA; FATTY ACID; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TRIACYLGLYCEROL;

DOWN REGULATION; DRUG SAFETY; DYSLIPIDEMIA; EDITORIAL; EXPERIMENTAL MODEL; HEALTH HAZARD; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; MEDICAL RESEARCH; NONHUMAN; PRIMATE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RISK ASSESSMENT; RODENT; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

EID: 37049001469     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm255     Document Type: Editorial

References (10)

1. Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., and Gonzalez, F. J. (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor-α. Cancer Res. 64, 3849-3854.
2. Hays, T., Rusyn, I., Burns, A. M., Kennett, M. J., Ward, J. M., Gonzalez, F. J., and Peters, J. M. (2005). Role of peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26, 219-227.
3. Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
4. Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003). PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33, 655-780.
5. Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., and Gonzalez, F. J. (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor α to Wy-14,643-induced liver tumorigenesis. Carcinogenesis 27, 1074-1080.
6. Peters, J. M., Cattley, R. C., and Gonzalez, F. J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18, 2029-2033.
7. Peters, J. M., Cheung, C., and Gonzalez, F. J. (2005). Peroxisome proliferator-activated receptor-alpha and liver cancer: Where do we stand? J. Mol. Med. 83, 774-785.
8. Reddy, J. K., Azamoff, D. L., and Hignite, C. E. (1980). Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283, 397-398.
9. Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., and Gonzalez, F. J. (2007). Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol. 27, 4238-4247.
10. Yang, Q., Nagano, T., Shah, Y., Cheung, C., Ito, S., and Gonzalez, F. J. (2007). The PPARα-humanized mouse: A model to investigate species differences in liver toxicity mediated by PPARα. Toxicol. Sci. doi: 10.1093/toxsci/kfm206.